|
|
xi | |
|
|
|
Section 1 History/Introduction |
|
|
1 | (12) |
|
|
3 | (2) |
|
|
1 A Brief History of Clinical Organ Transplantation |
|
|
5 | (8) |
|
|
Section 2 Transplantation Biology |
|
|
13 | (238) |
|
|
|
2 An Overview of Physiologic Immunity |
|
|
15 | (15) |
|
|
|
|
|
3 Transplant Antigens: A Brief History of HLA |
|
|
30 | (6) |
|
|
4 Transplant Antigen Biology |
|
|
36 | (14) |
|
|
|
|
|
5 Cellular Mechanisms of Adaptive Immunity |
|
|
50 | (10) |
|
|
6 Humoral Mechanisms of Adaptive Immunity |
|
|
60 | (8) |
|
|
|
|
68 | (11) |
|
|
|
|
8 Mechanisms of Immune Regulation |
|
|
79 | (8) |
|
|
|
|
9 The Spectrum of Alloimmunity, Heterologous Immunity, and Relevant Autoimmunity |
|
|
87 | (12) |
|
|
|
|
10 Fundamental Concepts Regarding Graft Injury and Regeneration: Tissue Injury, Tissue Quality, and Recipient Factors |
|
|
99 | (20) |
|
|
|
|
11 Mechanisms of Allograft Tolerance |
|
|
119 | (15) |
|
|
|
|
134 | (16) |
|
|
|
Experimental Transplantation |
|
|
|
13 In Vitro Models of Alloreactivity |
|
|
150 | (8) |
|
|
|
|
|
14 Small Animal Models of Transplantation |
|
|
158 | (27) |
|
|
|
|
15 Large Animal Models of Transplantation |
|
|
185 | (23) |
|
|
|
|
|
16 Advancing Transplantation In Silico: Studying Global Gene Expression Using Functional Genomics for Transplantation Research |
|
|
208 | (11) |
|
|
|
|
Mechanisms of Immune Modulation |
|
|
|
17 Current Pathways for Immune Manipulation |
|
|
219 | (20) |
|
|
|
|
|
|
18 Future Pathways for Immune Manipulation |
|
|
239 | (12) |
|
|
|
Section 3 Organ Procurement |
|
|
251 | (100) |
|
Organ Procurement and Allocation |
|
|
|
19 Administration of Organ Procurement and Allocation |
|
|
253 | (11) |
|
|
|
|
20 Deceased Donor Management |
|
|
264 | (13) |
|
|
|
|
|
Techniques for Organ Procurement |
|
|
|
21 Techniques for Organ Procurement after Brain Death |
|
|
277 | (11) |
|
|
|
|
|
|
22 Techniques for Organ Procurement after Circulatory Death |
|
|
288 | (5) |
|
Chandrasekar Santhanakrishnan |
|
|
|
23 Techniques for Living Donor Kidney Procurement |
|
|
293 | (16) |
|
|
|
|
24 Techniques for Living Donor Liver Procurement |
|
|
309 | (10) |
|
|
|
|
Organ Preservation and Resuscitation |
|
|
|
25 Abdominal Organ Preservation and Resuscitation |
|
|
319 | (15) |
|
|
|
26 Thoracic Organ Preservation and Resuscitation |
|
|
334 | (9) |
|
|
|
|
|
27 Kidney Paired Donation Networks |
|
|
343 | (8) |
|
|
|
Section 4 Pre-operative Management of Transplant Patients |
|
|
351 | (266) |
|
Patient Selection and Indications for Organ Transplantation |
|
|
|
28 Patient Selection and Indications for Kidney Transplantation |
|
|
353 | (11) |
|
|
|
29 Patient Selection and Indications for Liver Transplantation |
|
|
364 | (13) |
|
|
|
30 Patient Selection and Indications for Heart Transplantation |
|
|
377 | (11) |
|
|
|
31 Patient Selection and Indications for Lung Transplantation |
|
|
388 | (16) |
|
|
|
32 Patient Selection and Indications for Pancreas and Islet Transplantation |
|
|
404 | (8) |
|
|
|
33 Patient Selection and Indications for Intestinal and Multivisceral Organ Transplantation |
|
|
412 | (4) |
|
|
|
34 Role of Primary Care Provider in the Referral and Care of Abdominal Organ Transplant Patients |
|
|
416 | (12) |
|
|
|
|
35 Role of Primary Care Provider in the Referral and Care of Thoracic Organ Transplant Patients |
|
|
428 | (15) |
|
|
|
|
The Histocompatibility Lab |
|
|
|
36 Alloantibodies, Sensitization and Virtual Crossmatching |
|
|
443 | (9) |
|
|
|
|
|
37 Waiting List Management for Kidney Transplantation |
|
|
452 | (10) |
|
|
|
|
38 Waiting List Management for Liver Transplantation |
|
|
462 | (8) |
|
|
39 Waiting List Management for Heart Transplantation |
|
|
470 | (6) |
|
|
40 Waiting List Management for Lung Transplantation |
|
|
476 | (6) |
|
|
|
41 Waiting List Management for Pancreas and Islet Transplantation |
|
|
482 | (7) |
|
|
42 Waiting List Management for Intestinal and Multivisceral Transplantation |
|
|
489 | (6) |
|
|
|
Intensive Care in End Organ Failure |
|
|
|
43 Intensive Care in Hepatic Failure |
|
|
495 | (8) |
|
|
|
44 Intensive Care in Cardiac Failure |
|
|
503 | (17) |
|
|
|
|
|
45 Intensive Care in Pulmonary Failure |
|
|
520 | (10) |
|
|
|
Artificial Organs and Assist Devices |
|
|
|
|
530 | (15) |
|
|
|
47 The Artificial Liver, in vivo Tissue Engineering, and Organ Printing |
|
|
545 | (9) |
|
|
|
|
48 Ventricular Assist Devices |
|
|
554 | (9) |
|
|
|
|
563 | (5) |
|
|
|
|
|
|
568 | (8) |
|
|
|
51 The Artificial Pancreas |
|
|
576 | (8) |
|
|
|
52 Tissue and Organ Bioengineering |
|
|
584 | (10) |
|
|
|
Organ Acceptance and Risk Management Assessment |
|
|
|
53 Organ Assessment and Acceptance for Standard and Expanded Criteria Donors |
|
|
594 | (11) |
|
|
|
54 Organ Assessment and Acceptance for Donation after Circulatory Death Donors |
|
|
605 | (12) |
|
|
|
Section 5 Transplant Procedure and Surgical Technique |
|
|
617 | (98) |
|
55 Kidney Transplantation Procedure and Surgical Technique |
|
|
619 | (12) |
|
|
|
56 Liver Transplantation Procedure and Surgical Technique |
|
|
631 | (8) |
|
|
|
|
|
57 Living Donor Liver Transplantation Procedure and Surgical Technique |
|
|
639 | (18) |
|
|
|
|
58 Heart Transplantation Procedure and Surgical Technique |
|
|
657 | (10) |
|
|
|
|
|
59 Lung Transplantation Procedure and Surgical Technique |
|
|
667 | (7) |
|
|
|
60 Pancreas Transplantation Procedure and Surgical Technique |
|
|
674 | (8) |
|
|
|
|
61 Islet Cell Transplantation Procedure and Surgical Technique |
|
|
682 | (9) |
|
|
|
62 Intestinal Transplantation Procedure and Surgical Technique |
|
|
691 | (6) |
|
|
63 Multivisceral Transplantation Procedure and Surgical Technique |
|
|
697 | (6) |
|
|
|
64 Vascularized Composite Allograft Transplantation Procedure and Surgical Technique |
|
|
703 | (12) |
|
|
|
|
|
Index |
|
|
|
|
Section 6 Post-transplant Management |
|
|
715 | (542) |
|
Immunosuppressive Therapy |
|
|
|
65 Induction Immunosuppressive therapy |
|
|
717 | (15) |
|
|
|
66 Maintenance Immunosuppressive Therapy |
|
|
732 | (22) |
|
|
|
|
67 Rescue Immunosuppressive Therapy |
|
|
754 | (9) |
|
|
|
68 Desensitization Protocols for Organ Transplantation |
|
|
763 | (10) |
|
|
|
Clinical Allograft Rejection Syndromes: Diagnosis and Management |
|
|
|
69 Clinical Allograft Rejection Syndromes in Kidney Transplantation |
|
|
773 | (16) |
|
|
70 Clinical Allograft Rejection Syndromes in Liver Transplantation |
|
|
789 | (13) |
|
|
|
71 Clinical Allograft Rejection Syndromes in Heart Transplantation |
|
|
802 | (11) |
|
|
|
|
72 Clinical Allograft Rejection Syndromes in Lung Transplantation |
|
|
813 | (11) |
|
|
73 Clinical Allograft Rejection Syndromes in Pancreas and Islet Transplantation |
|
|
824 | (6) |
|
|
|
74 Clinical Allograft Rejection Syndromes in Intestinal Transplantation |
|
|
830 | (5) |
|
|
|
|
|
|
|
75 Clinical Allograft Rejection Syndromes in Vascularized Composite Allotransplantation |
|
|
835 | (9) |
|
|
|
76 Clinical Transplantation Tolerance |
|
|
844 | (11) |
|
|
|
|
Clinical Recurrent Disease: Diagnosis and Management |
|
|
|
77 Recurrent Disease after Kidney and Pancreas Transplantation |
|
|
855 | (14) |
|
|
|
78 Recurrent Disease after Liver Transplantation |
|
|
869 | (14) |
|
|
|
79 Recurrent Disease after Heart Transplantation |
|
|
883 | (15) |
|
|
|
80 Recurrent Disease after Lung Transplantation |
|
|
898 | (12) |
|
|
Histopathological Syndromes of Graft Rejection and Recurrent Disease |
|
|
|
81 Histopathological Syndromes of Kidney Allograft Rejection and Recurrent Disease |
|
|
910 | (17) |
|
|
|
82 Histopathological Syndromes of Liver Allograft Rejection and Recurrent Disease |
|
|
927 | (30) |
|
|
|
|
|
|
|
83 Histopathological Syndromes of Heart Allograft Rejection and Recurrent Disease |
|
|
957 | (24) |
|
|
|
84 Histopathological Syndromes of Lung Allograft Rejection and Recurrent Disease |
|
|
981 | (8) |
|
|
|
85 Histopathological Syndromes of Pancreas and Islet Allograft Rejection and Recurrent Disease |
|
|
989 | (22) |
|
Cinthia Beskow Drachenberg |
|
|
|
86 Histopathological Syndromes of Intestinal Allograft Rejection and Recurrent Disease |
|
|
1011 | (12) |
|
|
|
|
|
|
87 Histopathological Syndromes of Vascularized Composite Allograft Rejection and Recurrent Disease |
|
|
|
|
|
|
|
Post-operative Monitoring |
|
|
1023 | (7) |
|
88 Cardiovascular Disease and Preventive Healthcare after Organ Transplantation |
|
|
1030 | (29) |
|
|
|
89 Monitoring for HLA Antibody after Organ Transplantation |
|
|
1059 | (6) |
|
|
|
90 Biomarkers and Alloimmune Monitoring after Organ Transplantation |
|
|
1065 | (14) |
|
|
|
|
91 Protective Immune Competence after Organ Transplantation |
|
|
1079 | (9) |
|
|
Transplant Infectious Diseases |
|
|
|
92 Donor-derived Infections after Organ Transplantation |
|
|
1088 | (17) |
|
|
|
93 Perioperative Infections after Organ Transplantation |
|
|
1105 | (12) |
|
|
|
94 Late Infectious Disease after Organ Transplantation |
|
|
1117 | (17) |
|
|
|
Malignancy in Transplantation |
|
|
|
95 General Malignancy after Organ Transplantation |
|
|
1134 | (13) |
|
|
|
|
96 Post-Transplant Lymphoproliferative Disorders |
|
|
1147 | (14) |
|
|
|
Pregnancy and Contraception in Transplantation |
|
|
|
97 Pregnancy and Contraception in Transplantation |
|
|
1161 | (18) |
|
|
|
|
|
|
The Transplant Pharmacopeia |
|
|
|
98 Drugs Specifically Approved for Transplant Indications |
|
|
1179 | (23) |
|
|
|
99 Infectious Disease Prophylaxis after Organ Transplantation |
|
|
1202 | (11) |
|
|
100 Metabolic and Endocrine Management of the Organ Transplant Recipient |
|
|
1213 | (20) |
|
|
|
|
101 Off-Label Use of Immunosuppressive Agents in Solid Organ Transplantation |
|
|
1233 | (9) |
|
|
|
|
102 Drug Interactions in Organ Transplantation |
|
|
1242 | (15) |
|
|
|
|
Section 7 Long-term Transplant Outcomes |
|
|
1257 | (96) |
|
103 Long-term Outcomes after Kidney Transplantation |
|
|
1259 | (8) |
|
|
|
104 Long-term Outcomes after Liver Transplantation |
|
|
1267 | (13) |
|
|
|
|
105 Long-term Outcomes after Heart Transplantation |
|
|
1280 | (8) |
|
|
|
106 Long-term Outcomes after Lung and Heart-Lung Transplantation |
|
|
1288 | (12) |
|
|
|
|
107 Long-term Outcomes after Pancreas Transplantation |
|
|
1300 | (14) |
|
|
|
108 Long-term Outcomes after Islet Transplantation |
|
|
1314 | (20) |
|
|
|
109 Long-term Outcomes after Intestinal and Multi-visceral Transplantation |
|
|
1334 | (4) |
|
|
|
|
|
|
110 Long-term Outcomes after Vascularized Composite Allograft Transplantation |
|
|
1338 | (15) |
|
|
|
Section 8 Pediatric Transplant |
|
|
1353 | (136) |
|
111 An Introduction to Pediatric Organ Transplantation |
|
|
1355 | (2) |
|
|
|
112 Developmental Immunity: From Birth to Adult |
|
|
1357 | (13) |
|
|
|
113 Pediatric Kidney Transplantation |
|
|
1370 | (20) |
|
|
114 Pediatric Liver Transplantation |
|
|
1390 | (16) |
|
|
|
115 Pediatric Heart Transplantation |
|
|
1406 | (14) |
|
|
116 Pediatric Lung Transplantation |
|
|
1420 | (1) |
|
|
|
117 Pediatric Intestinal and Multivisceral Organ Transplantation |
|
|
1420 | (15) |
|
|
Special Pediatric Considerations |
|
|
|
118 Growth and Development after Organ Transplantation |
|
|
1435 | (8) |
|
|
119 Cognitive Development and Functional Outcomes after Organ Transplantation |
|
|
1443 | (10) |
|
|
|
|
120 Nonadherence, Psychosocial Adaptation and Its Effects in Pediatric Transplantation |
|
|
1453 | (22) |
|
|
|
121 Management of the Organ Transplant Recipient in the Transition from Pediatric to Adult Care |
|
|
1475 | (14) |
|
|
|
Section 9 Transplant Administration |
|
|
1489 | (92) |
|
122 Transplant Coordination |
|
|
1491 | (6) |
|
|
123 Transplant Pharmacy Services |
|
|
1497 | (12) |
|
|
|
|
|
|
|
124 Inpatient Transplant Unit Management |
|
|
1509 | (9) |
|
|
|
|
|
125 Transplant Clinic Management |
|
|
1518 | (15) |
|
|
|
|
|
126 Transplant Center Management and Leadership -- A Case for Structured Intrapreneurship |
|
|
1533 | (9) |
|
|
|
|
127 Transplant Quality Programs |
|
|
1542 | (7) |
|
|
|
|
128 National and International Transplant Management and Oversight |
|
|
1549 | (13) |
|
|
|
|
|
|
|
129 Abdominal Solid Organ Transplantation Fellowship Training |
|
|
1562 | (4) |
|
|
|
130 Medical Solid Organ Transplant Fellowship Training |
|
|
1566 | (6) |
|
|
|
131 Transplantation in General Medical Education |
|
|
1572 | (9) |
|
|
|
Section 10 Clinical Trials and Data Management |
|
|
1581 | (58) |
|
132 Building and Sustaining a Local Transplant Data Management Program |
|
|
1583 | (15) |
|
|
|
|
|
133 National Transplant Data Registries and Population Studies |
|
|
1598 | (9) |
|
|
|
134 Clinical Research Methods and Analysis in Organ Transplantation |
|
|
1607 | (15) |
|
|
|
135 Comparative Effectiveness in Transplantation |
|
|
1622 | (17) |
|
|
|
Section 11 Transplant Policy |
|
|
1639 | |
|
|
|
136 Transplant Ethics for Clinicians |
|
|
1641 | (4) |
|
|
|
137 The Ethics of Organ Allocation |
|
|
1645 | (9) |
|
|
|
138 The Ethics of Living Donation |
|
|
1654 | (8) |
|
|
|
139 Cultural Variations in Organ Transplantation |
|
|
1662 | (11) |
|
|
|
Economic and Societal Impact of Transplantation and Transplant Policy |
|
|
|
140 Federal and Private Insurance Coverage for Organ Transplantation |
|
|
1673 | (6) |
|
|
141 Drug Development in Solid Organ Transplantation and the Approval Process for Transplant Immunosuppressants |
|
|
1679 | (11) |
|
|
|
|
|
|
|
|
142 Organ Specific Benefits of Transplantation: Outcomes and Economics |
|
|
1690 | (13) |
|
|
|
|
143 National Healthcare Policy, Transplant-specific Statutes, and the Future of Organ Transplantation |
|
|
1703 | |
|
|
|
Index |
|